| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 6.63e-05 | 4 | 67 | 2 | GO:0030197 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 3.37e-06 | 10 | 64 | 3 | GO:0060397 | |
| GeneOntologyBiologicalProcess | mammary gland involution | 4.62e-06 | 11 | 64 | 3 | GO:0060056 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 2.84e-05 | 3 | 64 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 4.95e-05 | 65 | 64 | 4 | GO:0060443 | |
| GeneOntologyBiologicalProcess | hematopoietic or lymphoid organ development | 5.81e-05 | 133 | 64 | 5 | GO:0048534 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 7.04e-05 | 26 | 64 | 3 | GO:0060396 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 7.90e-05 | 27 | 64 | 3 | GO:0071378 | |
| GeneOntologyBiologicalProcess | immune system development | 1.19e-04 | 248 | 64 | 6 | GO:0002520 | |
| GeneOntologyBiologicalProcess | mammary gland development | 1.47e-04 | 162 | 64 | 5 | GO:0030879 | |
| GeneOntologyBiologicalProcess | reelin-mediated signaling pathway | 2.62e-04 | 8 | 64 | 2 | GO:0038026 | |
| GeneOntologyBiologicalProcess | response to interleukin-4 | 2.79e-04 | 41 | 64 | 3 | GO:0070670 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 2.79e-04 | 41 | 64 | 3 | GO:0060416 | |
| GeneOntologyBiologicalProcess | taurine metabolic process | 3.36e-04 | 9 | 64 | 2 | GO:0019530 | |
| GeneOntologyBiologicalProcess | alkanesulfonate metabolic process | 3.36e-04 | 9 | 64 | 2 | GO:0019694 | |
| GeneOntologyBiologicalProcess | mast cell proliferation | 3.36e-04 | 9 | 64 | 2 | GO:0070662 | |
| GeneOntologyBiologicalProcess | regulation of mast cell proliferation | 3.36e-04 | 9 | 64 | 2 | GO:0070666 | |
| GeneOntologyBiologicalProcess | interleukin-4-mediated signaling pathway | 4.20e-04 | 10 | 64 | 2 | GO:0035771 | |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 4.20e-04 | 10 | 64 | 2 | GO:0046543 | |
| GeneOntologyBiologicalProcess | negative regulation of erythrocyte differentiation | 5.12e-04 | 11 | 64 | 2 | GO:0045647 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 5.12e-04 | 11 | 64 | 2 | GO:0070669 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 6.13e-04 | 12 | 64 | 2 | GO:0045588 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell differentiation | 6.13e-04 | 12 | 64 | 2 | GO:0032825 | |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 6.13e-04 | 12 | 64 | 2 | GO:0070672 | |
| GeneOntologyBiologicalProcess | mucosa-associated lymphoid tissue development | 7.23e-04 | 13 | 64 | 2 | GO:0048537 | |
| GeneOntologyBiologicalProcess | Peyer's patch development | 7.23e-04 | 13 | 64 | 2 | GO:0048541 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 7.23e-04 | 13 | 64 | 2 | GO:0045136 | |
| GeneOntologyCellularComponent | stereocilium tip | 5.07e-05 | 22 | 69 | 3 | GO:0032426 | |
| GeneOntologyCellularComponent | actin-based cell projection | 3.11e-04 | 278 | 69 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | non-motile cilium | 4.76e-04 | 196 | 69 | 5 | GO:0097730 | |
| GeneOntologyCellularComponent | hemidesmosome | 5.79e-04 | 11 | 69 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 9.52e-04 | 14 | 69 | 2 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 9.52e-04 | 14 | 69 | 2 | GO:0060091 | |
| MousePheno | abnormal mechanoreceptor morphology | 3.18e-05 | 231 | 55 | 7 | MP:0000972 | |
| MousePheno | abnormal cochlear microphonics | 4.51e-05 | 18 | 55 | 3 | MP:0004412 | |
| MousePheno | abnormal cochlear potential | 5.34e-05 | 19 | 55 | 3 | MP:0006332 | |
| MousePheno | abnormal cochlear hair cell morphology | 1.36e-04 | 202 | 55 | 6 | MP:0002622 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 1.55e-04 | 207 | 55 | 6 | MP:0003308 | |
| MousePheno | abnormal organ of Corti morphology | 1.64e-04 | 209 | 55 | 6 | MP:0000042 | |
| MousePheno | abnormal cochlear outer hair cell physiology | 1.76e-04 | 28 | 55 | 3 | MP:0004434 | |
| MousePheno | abnormal hair cell morphology | 1.86e-04 | 214 | 55 | 6 | MP:0000045 | |
| MousePheno | abnormal defecation | 2.72e-04 | 80 | 55 | 4 | MP:0003866 | |
| MousePheno | abnormal cochlear labyrinth morphology | 3.08e-04 | 235 | 55 | 6 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 3.08e-04 | 235 | 55 | 6 | MP:0003169 | |
| MousePheno | Meibomian gland atrophy | 3.15e-04 | 7 | 55 | 2 | MP:0001345 | |
| MousePheno | abnormal mammary gland physiology | 3.91e-04 | 88 | 55 | 4 | MP:0001881 | |
| MousePheno | abnormal apocrine gland physiology | 3.91e-04 | 88 | 55 | 4 | MP:0013555 | |
| MousePheno | abnormal cochlear outer hair cell morphology | 3.93e-04 | 159 | 55 | 5 | MP:0004399 | |
| MousePheno | abnormal cochlea morphology | 4.11e-04 | 248 | 55 | 6 | MP:0000031 | |
| MousePheno | abnormal cochlear hair cell stereociliary bundle morphology | 4.45e-04 | 91 | 55 | 4 | MP:0004521 | |
| MousePheno | abnormal ear morphology | 4.67e-04 | 470 | 55 | 8 | MP:0002102 | |
| MousePheno | abnormal skin adnexa physiology | 4.92e-04 | 167 | 55 | 5 | MP:0010680 | |
| MousePheno | abnormal cochlear hair cell physiology | 5.14e-04 | 40 | 55 | 3 | MP:0004432 | |
| MousePheno | small Meibomian gland | 5.38e-04 | 9 | 55 | 2 | MP:0013388 | |
| MousePheno | abnormal membranous labyrinth morphology | 5.50e-04 | 262 | 55 | 6 | MP:0000035 | |
| MousePheno | abnormal cranial ganglia morphology | 6.09e-04 | 175 | 55 | 5 | MP:0001081 | |
| Domain | STAT_TF_prot_interaction | 1.60e-06 | 7 | 68 | 3 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 1.60e-06 | 7 | 68 | 3 | IPR012345 | |
| Domain | STAT | 1.60e-06 | 7 | 68 | 3 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 1.60e-06 | 7 | 68 | 3 | IPR015988 | |
| Domain | - | 1.60e-06 | 7 | 68 | 3 | 2.60.40.630 | |
| Domain | STAT_int | 1.60e-06 | 7 | 68 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.60e-06 | 7 | 68 | 3 | IPR013801 | |
| Domain | STAT_bind | 1.60e-06 | 7 | 68 | 3 | PF02864 | |
| Domain | STAT_int | 1.60e-06 | 7 | 68 | 3 | PF02865 | |
| Domain | - | 1.60e-06 | 7 | 68 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.60e-06 | 7 | 68 | 3 | PF01017 | |
| Domain | - | 1.60e-06 | 7 | 68 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_alpha | 2.55e-06 | 8 | 68 | 3 | IPR013800 | |
| Domain | SH2 | 3.33e-05 | 101 | 68 | 5 | PF00017 | |
| Domain | p53-like_TF_DNA-bd | 4.11e-05 | 53 | 68 | 4 | IPR008967 | |
| Domain | SH2 | 5.02e-05 | 110 | 68 | 5 | SM00252 | |
| Domain | SH2 | 5.24e-05 | 111 | 68 | 5 | PS50001 | |
| Domain | SH2 | 5.47e-05 | 112 | 68 | 5 | IPR000980 | |
| Domain | - | 5.47e-05 | 112 | 68 | 5 | 3.30.505.10 | |
| Domain | Pectin_lyase_fold/virulence | 3.61e-04 | 8 | 68 | 2 | IPR011050 | |
| Domain | - | 3.73e-04 | 261 | 68 | 6 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 6.15e-04 | 287 | 68 | 6 | IPR011992 | |
| Domain | SEA | 1.16e-03 | 14 | 68 | 2 | SM00200 | |
| Domain | VWD | 1.52e-03 | 16 | 68 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.52e-03 | 16 | 68 | 2 | IPR001846 | |
| Domain | VWFD | 1.52e-03 | 16 | 68 | 2 | PS51233 | |
| Domain | VWD | 1.52e-03 | 16 | 68 | 2 | PF00094 | |
| Domain | EGF | 1.65e-03 | 235 | 68 | 5 | SM00181 | |
| Domain | - | 2.09e-03 | 248 | 68 | 5 | 1.25.40.20 | |
| Domain | EGF-like_dom | 2.13e-03 | 249 | 68 | 5 | IPR000742 | |
| Domain | ANK | 2.20e-03 | 251 | 68 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 2.28e-03 | 253 | 68 | 5 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.32e-03 | 254 | 68 | 5 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.32e-03 | 254 | 68 | 5 | PS50297 | |
| Domain | Ankyrin_rpt | 2.65e-03 | 262 | 68 | 5 | IPR002110 | |
| Domain | Actinin_actin-bd_CS | 3.15e-03 | 23 | 68 | 2 | IPR001589 | |
| Domain | Spectrin | 3.15e-03 | 23 | 68 | 2 | PF00435 | |
| Domain | SEA | 3.15e-03 | 23 | 68 | 2 | PS50024 | |
| Domain | SEA_dom | 3.15e-03 | 23 | 68 | 2 | IPR000082 | |
| Domain | ACTININ_2 | 3.15e-03 | 23 | 68 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.15e-03 | 23 | 68 | 2 | PS00019 | |
| Domain | Spectrin_repeat | 4.98e-03 | 29 | 68 | 2 | IPR002017 | |
| Domain | JMJC | 6.04e-03 | 32 | 68 | 2 | PS51184 | |
| Domain | Spectrin/alpha-actinin | 6.04e-03 | 32 | 68 | 2 | IPR018159 | |
| Domain | JmjC_dom | 6.04e-03 | 32 | 68 | 2 | IPR003347 | |
| Domain | SPEC | 6.04e-03 | 32 | 68 | 2 | SM00150 | |
| Domain | JmjC | 6.41e-03 | 33 | 68 | 2 | SM00558 | |
| Domain | Ig_E-set | 6.47e-03 | 104 | 68 | 3 | IPR014756 | |
| Domain | Sc_DH/Rdtase_CS | 7.19e-03 | 35 | 68 | 2 | IPR020904 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 1.96e-06 | 27 | 48 | 4 | MM14712 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 2.64e-06 | 29 | 48 | 4 | M779 | |
| Pathway | PID_EPO_PATHWAY | 4.50e-06 | 33 | 48 | 4 | M233 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 1.90e-05 | 47 | 48 | 4 | M39380 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 2.18e-05 | 100 | 48 | 5 | MM15879 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 2.44e-05 | 17 | 48 | 3 | M47905 | |
| Pathway | WP_IL4_SIGNALING | 3.30e-05 | 54 | 48 | 4 | M39720 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.09e-05 | 57 | 48 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.39e-05 | 58 | 48 | 4 | M2049 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 6.25e-05 | 23 | 48 | 3 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 6.25e-05 | 23 | 48 | 3 | M7897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 6.25e-05 | 23 | 48 | 3 | M47904 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 7.13e-05 | 24 | 48 | 3 | M11520 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 8.08e-05 | 25 | 48 | 3 | MM1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 8.08e-05 | 25 | 48 | 3 | M27865 | |
| Pathway | WP_IL5_SIGNALING_PATHWAY | 8.21e-05 | 68 | 48 | 4 | MM15930 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 1.08e-04 | 73 | 48 | 4 | M321 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.13e-04 | 5 | 48 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 1.13e-04 | 5 | 48 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 1.13e-04 | 5 | 48 | 2 | M49006 | |
| Pathway | WP_PDGFRBETA_PATHWAY | 1.27e-04 | 29 | 48 | 3 | M39616 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.56e-04 | 151 | 48 | 5 | M39801 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.69e-04 | 6 | 48 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.69e-04 | 6 | 48 | 2 | MM15621 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 2.14e-04 | 87 | 48 | 4 | MM15915 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 2.36e-04 | 7 | 48 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 2.36e-04 | 7 | 48 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 2.36e-04 | 7 | 48 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 2.36e-04 | 7 | 48 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 2.36e-04 | 7 | 48 | 2 | M27907 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 2.44e-04 | 36 | 48 | 3 | MM1418 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 2.65e-04 | 37 | 48 | 3 | M8615 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 3.61e-04 | 41 | 48 | 3 | MM15162 | |
| Pathway | PID_CXCR4_PATHWAY | 3.65e-04 | 100 | 48 | 4 | M124 | |
| Pathway | WP_IL2_SIGNALING | 3.87e-04 | 42 | 48 | 3 | M39536 | |
| Pathway | PID_TCPTP_PATHWAY | 3.87e-04 | 42 | 48 | 3 | M91 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 4.03e-04 | 9 | 48 | 2 | MM15117 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 4.03e-04 | 9 | 48 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 4.03e-04 | 9 | 48 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 4.03e-04 | 9 | 48 | 2 | M8066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 4.76e-04 | 45 | 48 | 3 | M47408 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 5.02e-04 | 10 | 48 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 5.02e-04 | 10 | 48 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 5.02e-04 | 10 | 48 | 2 | MM15618 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 5.75e-04 | 48 | 48 | 3 | M914 | |
| Pathway | WP_IL3_SIGNALING | 6.12e-04 | 49 | 48 | 3 | M39722 | |
| Pathway | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | 6.12e-04 | 49 | 48 | 3 | M92 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 6.12e-04 | 11 | 48 | 2 | M27372 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 6.12e-04 | 11 | 48 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 6.12e-04 | 11 | 48 | 2 | MM15578 | |
| Pathway | PID_PTP1B_PATHWAY | 7.28e-04 | 52 | 48 | 3 | M50 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 7.33e-04 | 12 | 48 | 2 | M27893 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 9.53e-04 | 57 | 48 | 3 | M19888 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.01e-03 | 14 | 48 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 1.01e-03 | 14 | 48 | 2 | M135 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 1.05e-03 | 59 | 48 | 3 | M39350 | |
| Pathway | WP_FOXP3_IN_COVID19 | 1.16e-03 | 15 | 48 | 2 | M42573 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.16e-03 | 15 | 48 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.16e-03 | 15 | 48 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.16e-03 | 15 | 48 | 2 | M17681 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 1.16e-03 | 15 | 48 | 2 | MM14536 | |
| Pathway | PID_IL12_2PATHWAY | 1.22e-03 | 62 | 48 | 3 | M54 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.32e-03 | 16 | 48 | 2 | MM15710 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.32e-03 | 16 | 48 | 2 | M27410 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.32e-03 | 16 | 48 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.32e-03 | 16 | 48 | 2 | MM1420 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.32e-03 | 16 | 48 | 2 | M41733 | |
| Pathway | PID_IL4_2PATHWAY | 1.33e-03 | 64 | 48 | 3 | M28 | |
| Pathway | WP_ONCOSTATIN_M_SIGNALING | 1.40e-03 | 65 | 48 | 3 | M39562 | |
| Pathway | WP_AGERAGE_PATHWAY | 1.46e-03 | 66 | 48 | 3 | M39420 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.49e-03 | 17 | 48 | 2 | M27412 | |
| Pathway | WP_IL9_SIGNALING | 1.49e-03 | 17 | 48 | 2 | M39644 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.59e-03 | 68 | 48 | 3 | M39456 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 1.59e-03 | 68 | 48 | 3 | M48322 | |
| Pathway | WP_TH17_CELL_DIFFERENTIATION_PATHWAY | 1.66e-03 | 69 | 48 | 3 | M45541 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 1.68e-03 | 18 | 48 | 2 | M673 | |
| Pathway | WP_ULCERATIVE_COLITIS_SIGNALING | 1.68e-03 | 18 | 48 | 2 | M45536 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 1.80e-03 | 71 | 48 | 3 | MM15947 | |
| Pathway | WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME | 1.80e-03 | 71 | 48 | 3 | M39860 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 1.87e-03 | 19 | 48 | 2 | M41732 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 1.87e-03 | 19 | 48 | 2 | M12836 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 2.07e-03 | 20 | 48 | 2 | MM15496 | |
| Pathway | REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION | 2.07e-03 | 20 | 48 | 2 | MM14888 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 2.07e-03 | 20 | 48 | 2 | MM1389 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 2.07e-03 | 20 | 48 | 2 | M39002 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.07e-03 | 20 | 48 | 2 | M47517 | |
| Pathway | WP_PROLACTIN_SIGNALING | 2.19e-03 | 76 | 48 | 3 | M39601 | |
| Pathway | WP_EGFEGFR_SIGNALING | 2.21e-03 | 162 | 48 | 4 | M39334 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.51e-03 | 22 | 48 | 2 | M7747 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | 2.58e-03 | 281 | 48 | 5 | MM15130 | |
| Pathway | PID_REG_GR_PATHWAY | 2.72e-03 | 82 | 48 | 3 | M115 | |
| Pathway | REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION | 2.74e-03 | 23 | 48 | 2 | M27174 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.74e-03 | 23 | 48 | 2 | M556 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.74e-03 | 23 | 48 | 2 | MM1411 | |
| Pathway | WP_LDL_INFLUENCE_ON_CD14_AND_TLR4 | 2.74e-03 | 23 | 48 | 2 | M45556 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 2.99e-03 | 24 | 48 | 2 | M519 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 3.21e-03 | 87 | 48 | 3 | M12467 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 3.24e-03 | 25 | 48 | 2 | M41829 | |
| Pathway | WP_IL7_SIGNALING | 3.24e-03 | 25 | 48 | 2 | M39499 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 3.50e-03 | 26 | 48 | 2 | M27750 | |
| Pubmed | Stat5a regulates T helper cell differentiation by several distinct mechanisms. | 7.81e-09 | 3 | 70 | 3 | 11290598 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 9657743 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 25352693 | ||
| Pubmed | Thrombopoietin and interleukin-2 induce association of CRK with STAT5. | 3.12e-08 | 4 | 70 | 3 | 11097834 | |
| Pubmed | Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. | 3.12e-08 | 4 | 70 | 3 | 16365403 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 28422733 | ||
| Pubmed | 5.95e-08 | 371 | 70 | 9 | 25241761 | ||
| Pubmed | STAT5 promotes accessibility and is required for BATF-mediated plasticity at the Il9 locus. | 7.79e-08 | 5 | 70 | 3 | 32985505 | |
| Pubmed | Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. | 7.79e-08 | 5 | 70 | 3 | 17227909 | |
| Pubmed | The Current STATus of lymphocyte signaling: new roles for old players. | 7.79e-08 | 5 | 70 | 3 | 19362457 | |
| Pubmed | Sensitivity and resistance to regulation by IL-4 during Th17 maturation. | 1.55e-07 | 6 | 70 | 3 | 21949021 | |
| Pubmed | N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. | 1.55e-07 | 6 | 70 | 3 | 14704793 | |
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 17182563 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 10675904 | ||
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 20118929 | ||
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 23797472 | ||
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 2.72e-07 | 7 | 70 | 3 | 12039028 | |
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 2.72e-07 | 7 | 70 | 3 | 12634107 | |
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 2.72e-07 | 7 | 70 | 3 | 24058793 | |
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 2.72e-07 | 7 | 70 | 3 | 10526573 | |
| Pubmed | Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. | 3.44e-07 | 29 | 70 | 4 | 20716621 | |
| Pubmed | 4.34e-07 | 8 | 70 | 3 | 23727894 | ||
| Pubmed | 4.34e-07 | 8 | 70 | 3 | 27879203 | ||
| Pubmed | Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. | 4.34e-07 | 8 | 70 | 3 | 9989503 | |
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 10781830 | ||
| Pubmed | 6.50e-07 | 9 | 70 | 3 | 23435120 | ||
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 10200816 | ||
| Pubmed | JAK-STAT signaling maintains homeostasis in T cells and macrophages. | 9.28e-07 | 10 | 70 | 3 | 38658806 | |
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 24069548 | ||
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 37550517 | ||
| Pubmed | Distribution of the mammalian Stat gene family in mouse chromosomes. | 2.20e-06 | 13 | 70 | 3 | 8530075 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23151802 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26999798 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 3.99e-06 | 2 | 70 | 2 | 31443474 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12377952 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10825303 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 3.99e-06 | 2 | 70 | 2 | 21127177 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16289657 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25552366 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 3.99e-06 | 2 | 70 | 2 | 21431790 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28500076 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21826656 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7720707 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 3.99e-06 | 2 | 70 | 2 | 27264955 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22159083 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20008792 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 33199496 | ||
| Pubmed | STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis. | 3.99e-06 | 2 | 70 | 2 | 24845637 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 37106040 | ||
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 3.99e-06 | 2 | 70 | 2 | 10973822 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16502315 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12217382 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 9837784 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31599926 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10594041 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21036145 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10486277 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 3.99e-06 | 2 | 70 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 3.99e-06 | 2 | 70 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 3.99e-06 | 2 | 70 | 2 | 30377054 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 3.99e-06 | 2 | 70 | 2 | 32790723 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20576420 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 18492722 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10066807 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10835485 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 35464049 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 3.99e-06 | 2 | 70 | 2 | 23773921 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 34910522 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24145029 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 3.99e-06 | 2 | 70 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 3.99e-06 | 2 | 70 | 2 | 24878107 | |
| Pubmed | STAT5a and STAT6 gene expression levels in multiple sclerosis patients. | 3.99e-06 | 2 | 70 | 2 | 29126764 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12847485 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12835478 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7568026 | ||
| Pubmed | Identification of STAT5A and STAT5B target genes in human T cells. | 3.99e-06 | 2 | 70 | 2 | 24497979 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17536022 | ||
| Pubmed | STAT5 transcriptional activity is impaired by LIF in a mammary epithelial cell line. | 3.99e-06 | 2 | 70 | 2 | 17382296 | |
| Pubmed | STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation. | 3.99e-06 | 2 | 70 | 2 | 17911616 | |
| Pubmed | STAT5 signaling in sexually dimorphic gene expression and growth patterns. | 3.99e-06 | 2 | 70 | 2 | 10486314 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17599554 | ||
| Pubmed | MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation. | 3.99e-06 | 2 | 70 | 2 | 24497923 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24335105 | ||
| Pubmed | Brain STAT5 signaling modulates learning and memory formation. | 3.99e-06 | 2 | 70 | 2 | 29460051 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28606561 | ||
| Pubmed | Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. | 3.99e-06 | 2 | 70 | 2 | 12393407 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12039059 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21178171 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 3.99e-06 | 2 | 70 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 3.99e-06 | 2 | 70 | 2 | 16775227 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17447893 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15557282 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12958310 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16115927 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23275557 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 11867689 | ||
| Interaction | KRT5 interactions | 2.46e-07 | 193 | 67 | 8 | int:KRT5 | |
| Interaction | KRT14 interactions | 3.43e-06 | 192 | 67 | 7 | int:KRT14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 7.85e-05 | 147 | 70 | 4 | chr15q15 | |
| Cytoband | 15q15.3 | 6.72e-04 | 25 | 70 | 2 | 15q15.3 | |
| Cytoband | 7q22 | 1.55e-03 | 38 | 70 | 2 | 7q22 | |
| GeneFamily | SH2 domain containing | 1.50e-05 | 101 | 56 | 5 | 741 | |
| GeneFamily | CD molecules|Mucins | 3.60e-05 | 21 | 56 | 3 | 648 | |
| GeneFamily | Ankyrin repeat domain containing | 9.03e-04 | 242 | 56 | 5 | 403 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 1.69e-03 | 76 | 56 | 3 | 743 | |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | 9.48e-07 | 199 | 69 | 7 | M7099 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-07 | 183 | 69 | 6 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-07 | 183 | 69 | 6 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.41e-07 | 198 | 69 | 6 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.39e-06 | 178 | 69 | 5 | 9e1f2596fcea5b79cc50b58d83706bb8605e224f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.39e-06 | 178 | 69 | 5 | aa659bd283c4dfbe292cd8698bbf6b1999ca3314 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.39e-06 | 178 | 69 | 5 | bf1d273802a4f42e52ea1bd2a0cae2039559c093 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 9.59e-06 | 183 | 69 | 5 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.37e-05 | 197 | 69 | 5 | fd5fdc5289d681d59ff22d72e4de6e74c6c7aac6 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.47e-05 | 200 | 69 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.90e-05 | 151 | 69 | 4 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.84e-05 | 155 | 69 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 1.11e-04 | 160 | 69 | 4 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 161 | 69 | 4 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-04 | 162 | 69 | 4 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.17e-04 | 162 | 69 | 4 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.19e-04 | 163 | 69 | 4 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | C_02|World / shred on cell type and cluster | 1.25e-04 | 165 | 69 | 4 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1-Inhibitory_Neuron.Gad1Gad2_Pvalb.Tac1_(Interneuron,_Basket_1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 65 | 69 | 3 | 25d2f56f6cd982a227772f8a3b453cdcc8516a47 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1-Inhibitory_Neuron.Gad1Gad2_Pvalb.Tac1_(Interneuron,_Basket_1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 65 | 69 | 3 | d7d571be0662967e6d8d934e45f928a2f9e1c06a | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.44e-04 | 171 | 69 | 4 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-04 | 171 | 69 | 4 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B-ABC_aged-B_memory|Liver / Manually curated celltypes from each tissue | 1.44e-04 | 171 | 69 | 4 | eb47f4a09a630ed14a0898377039ed50ef7cc292 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.50e-04 | 173 | 69 | 4 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.50e-04 | 173 | 69 | 4 | 23248019c819f6e38337dcc4edb763ef1992e89e | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 1.54e-04 | 174 | 69 | 4 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 176 | 69 | 4 | 867936a20f73f638055c19c8d88834aa2cc657cf | |
| ToppCell | Healthy-RBC|World / disease group, cell group and cell class | 1.64e-04 | 177 | 69 | 4 | 2ce41e37fa7139c7bd2b464bd86c5601dc501515 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 177 | 69 | 4 | 37d1abe1a9d8f2b8f4d146bbf1db94104eab6593 | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 1.64e-04 | 177 | 69 | 4 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | Healthy-RBC|Healthy / disease group, cell group and cell class | 1.64e-04 | 177 | 69 | 4 | 945d72ab52efa9a9468daace9f9ec676a891d963 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-04 | 182 | 69 | 4 | 9c120ddd109103ef6fac9c32b84d16a7624d0580 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-04 | 183 | 69 | 4 | 82fe14fc7039415de41bdfd615a1380bed99f560 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.86e-04 | 183 | 69 | 4 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.90e-04 | 184 | 69 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.94e-04 | 185 | 69 | 4 | 53960307c6710401c3d52a766c3f4704ace9637f | |
| ToppCell | BLOOD--(2)_B_cell| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.98e-04 | 186 | 69 | 4 | d9f2cab7f9e7aa476d9bcf5d15896113e59e03f8 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.06e-04 | 188 | 69 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.06e-04 | 188 | 69 | 4 | 18d16e3f095a109b6a690f46fe7fcd5674c3636b | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.06e-04 | 188 | 69 | 4 | e5ab89030783461e9367ab87c353fb5c31911020 | |
| ToppCell | normal-na-Lymphocytic_B-B_atypical|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.06e-04 | 188 | 69 | 4 | 13653481d64c7a1ad833d738a3ee0bb9def7cec7 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Tac1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.07e-04 | 74 | 69 | 3 | c652ef04a1b8716b954ce913daa481cc02f4d44e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 189 | 69 | 4 | 2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 189 | 69 | 4 | 27e5d706f10a6221f314faf642eede15deab3165 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 2.15e-04 | 190 | 69 | 4 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | BLOOD--(2)_Memory_B_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.24e-04 | 192 | 69 | 4 | 9c3a4699f05f1a757d6e37d9f15675e970584cca | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 192 | 69 | 4 | e19e3e8edcc08e4a67873bfb6e46489ca6c8756a | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.24e-04 | 192 | 69 | 4 | f9f64ad7bab1433e9a45adb7db7f43ce3f591b47 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.24e-04 | 192 | 69 | 4 | 4884fd8ffa6fd6c30d7ac6bf447456b3397eabc5 | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 2.24e-04 | 192 | 69 | 4 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 192 | 69 | 4 | 61c2caf6c838132ed5faa8791c288f2149eba2c8 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.24e-04 | 192 | 69 | 4 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | normal-na-Lymphocytic_B-B_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.28e-04 | 193 | 69 | 4 | 2fd1cc050c775360cd53872fd405cf78288d7c4d | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 2.28e-04 | 193 | 69 | 4 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.28e-04 | 193 | 69 | 4 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.28e-04 | 193 | 69 | 4 | 8f1d6024ef092923321e6efd441b8d476db70aed | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.28e-04 | 193 | 69 | 4 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 193 | 69 | 4 | 1526f51b589a7dc7a28f35f0e788dc38d338d2bc | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.28e-04 | 193 | 69 | 4 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.28e-04 | 193 | 69 | 4 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 193 | 69 | 4 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | MS-naiveBc|MS / Condition, Cell_class and T cell subcluster | 2.33e-04 | 194 | 69 | 4 | aa4aa0a61275610054b583f60d5d41ecc4f88a0d | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-04 | 194 | 69 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | ILEUM-inflamed-(6)_ILC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.33e-04 | 194 | 69 | 4 | 4d51d49366c34ff1241770b4acc0167a43b3155a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-04 | 194 | 69 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | MS-naiveBc-|MS / Condition, Cell_class and T cell subcluster | 2.33e-04 | 194 | 69 | 4 | 1757787246a7862f9709834efc62bac61d70b906 | |
| ToppCell | HSPCs-Mk_prog.|World / Lineage and Cell class | 2.33e-04 | 194 | 69 | 4 | 5049f4f102844d766eca577e809cf21f7908a9d2 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-04 | 77 | 69 | 3 | ebb1a537751739232820a60f88911877fc683855 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 2.37e-04 | 195 | 69 | 4 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | ILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.37e-04 | 195 | 69 | 4 | c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.37e-04 | 195 | 69 | 4 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 2.47e-04 | 197 | 69 | 4 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 2.47e-04 | 197 | 69 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-04 | 198 | 69 | 4 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-04 | 198 | 69 | 4 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 2.52e-04 | 198 | 69 | 4 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.52e-04 | 198 | 69 | 4 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Control-Control-Lymphocyte-B-B_intermediate|Control / Disease, condition lineage and cell class | 2.56e-04 | 199 | 69 | 4 | ee6f07eec7edfe41d2f7fcb0b509ce00e99a6a95 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-04 | 199 | 69 | 4 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.61e-04 | 200 | 69 | 4 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 69 | 4 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 69 | 4 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.61e-04 | 200 | 69 | 4 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 2.61e-04 | 200 | 69 | 4 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.61e-04 | 200 | 69 | 4 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 69 | 4 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-B-B_intermediate|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.61e-04 | 200 | 69 | 4 | e945dd467dc90b8042982051d1bf76b72a4baf5b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.80e-04 | 82 | 69 | 3 | 7f0ee8dafc37c3628506397f88fbb98fc6420bfb | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.80e-04 | 82 | 69 | 3 | c8242d273513e99107c154afb489980d11008555 | |
| Drug | quizartinib | 7.45e-06 | 13 | 69 | 3 | ctd:C544967 | |
| Drug | androstan-3-ol | 9.12e-06 | 160 | 69 | 6 | CID000092877 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 5.08e-06 | 2 | 67 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 2.80e-05 | 26 | 67 | 3 | DOID:234 (is_implicated_in) | |
| Disease | gastric adenocarcinoma (is_marker_for) | 3.52e-05 | 28 | 67 | 3 | DOID:3717 (is_marker_for) | |
| Disease | lung carcinoma (is_marker_for) | 5.06e-05 | 5 | 67 | 2 | DOID:3905 (is_marker_for) | |
| Disease | Congenital ichthyosis of skin | 2.76e-04 | 11 | 67 | 2 | cv:C0020758 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 2.76e-04 | 11 | 67 | 2 | C0079154 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 3.66e-04 | 61 | 67 | 3 | DOID:3587 (is_marker_for) | |
| Disease | peanut allergy measurement | 5.97e-04 | 16 | 67 | 2 | EFO_0007017 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 9.05e-04 | 328 | 67 | 5 | EFO_0008377, EFO_0008378 | |
| Disease | migraine disorder, Headache | 1.00e-03 | 86 | 67 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 1.72e-03 | 27 | 67 | 2 | DOID:0050861 (is_marker_for) | |
| Disease | fatty liver disease (implicated_via_orthology) | 2.26e-03 | 31 | 67 | 2 | DOID:9452 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGLQNGEGQRGRIWI | 311 | P16452 | |
| VLAANGWNLKNGGTL | 166 | P14060 | |
| GNGKLGLVEFNILWN | 601 | P07384 | |
| QAWLQENLGIILGVG | 221 | P27701 | |
| QTLQLGWNGLLVLKN | 716 | Q8NDT2 | |
| IGANWRKTDIKGNNI | 661 | Q7Z5J8 | |
| TWQINGTGLLGKRND | 4871 | Q99102 | |
| QARLWKNLQLGVGRS | 21 | Q6DN14 | |
| NKQQGKRGWGQLTSN | 171 | Q9NWT6 | |
| QGKQQDVNWLGQGLI | 5336 | Q03001 | |
| QSLGNWRIKRQVLEG | 496 | Q03252 | |
| ETKWALLQEQGQNLG | 171 | Q5XKE5 | |
| LQWLLSQGGCRVQDK | 86 | B1AK53 | |
| LLWQGIGVGQLQLTE | 296 | Q96EX3 | |
| GGEEEWGQQQRQLGK | 136 | O94992 | |
| GIQRTLQGNLWGTEA | 876 | O43593 | |
| QLQTRCQNGGQWDGL | 2981 | Q02505 | |
| EKWLQRHSQGQGALG | 36 | Q9HCR9 | |
| QGGLNAGLKATVWIN | 196 | Q8TBE9 | |
| WLKQEQLRLQGLQGS | 941 | O43896 | |
| LAQKRGALQGSAWQV | 626 | Q9Y4W2 | |
| QQGRWNNVKPIRLNG | 396 | P23229 | |
| INGQWEGEVNGRKGL | 271 | P46109 | |
| GNIGSSNWGLNLLQE | 931 | Q6R327 | |
| VWSKGGLQLQANGRR | 3921 | Q5VST9 | |
| GATKVLLQEQGWQRL | 316 | Q96JP2 | |
| KGNGESLWQRQRLQS | 276 | Q9UHM6 | |
| DGKNLVQEWLAKRQG | 251 | P05187 | |
| GRQNAIKCGWLRKQG | 16 | Q8N264 | |
| GTNLWGENKKNRAVI | 666 | P49619 | |
| QLLASGGNDNKLLVW | 326 | Q9UM11 | |
| KVGEQGLWALVNNAG | 96 | Q8NEX9 | |
| IRRNKIWGGQNGGIL | 676 | Q86XK2 | |
| RQKAGVQVWLGANGK | 5341 | Q9Y6R7 | |
| IQQWLLKIGNEINNG | 676 | Q5T1B0 | |
| WKLSQIRKQLNQGEG | 256 | Q9UN19 | |
| GLEIWTNGNLINIVG | 261 | Q13443 | |
| KNNDNGAWVRGGDII | 781 | Q9UHN6 | |
| WEKGVVFINGQNLGR | 571 | Q8IW92 | |
| GLLQRWEVSGGQQAL | 76 | Q8N9H9 | |
| KQWGLQALQSQADLG | 96 | Q9BQA5 | |
| IEKRQVNQGLNLGWC | 491 | Q96MH7 | |
| ILKNGAGNWLAQQIR | 351 | Q8IZU8 | |
| LRQQGAEAWLKAKQG | 286 | Q6NT55 | |
| RLQEQGLQGWKSGGD | 41 | Q8TEY5 | |
| VKQEALRWVQGQGQG | 571 | P59044 | |
| LQTRCQNGGQWDGLK | 896 | Q9H195 | |
| GTEQWLQQLQDLRKG | 96 | Q6P0A1 | |
| SWGGLNQTQLRKILA | 166 | P03891 | |
| GGWVQQVALKQVGRR | 336 | Q8TDU9 | |
| AQNLKARQQLGAWGG | 166 | Q3SY00 | |
| VRDKGLWGLVNNAGI | 101 | O75452 | |
| GGSRAQEQKPLQQLW | 241 | Q9Y6U7 | |
| WNKDGNLRLGVQKGV | 246 | Q9C0D5 | |
| ELIQWKRRQQLAGNG | 251 | P51692 | |
| RNLALLVGWEQQGGE | 576 | Q6P9B9 | |
| CQGGNLQQLLLWGVR | 281 | Q7RTU9 | |
| LGQQGQELKVLWEQR | 1186 | Q9NRC6 | |
| ELIQWKRRQQLAGNG | 251 | P42229 | |
| IQIWKRQQQLAGNGA | 201 | P42226 | |
| ATKRDQNLKRGNWGN | 91 | P48067 | |
| QKAQIIGSQRENGWA | 416 | Q8IYQ7 | |
| QGETNKNRTKGGWQQ | 501 | Q9UGP8 | |
| QQTQGKLGAWEKDLG | 166 | Q6UXR4 | |
| NLNKSQLKLGIWGGN | 21 | Q709C8 | |
| QLKLGIWGGNVALDN | 26 | Q709C8 | |
| QAGLAQWSRQKGLAL | 6 | Q6Q795 | |
| SQLNNRLQGTKAWIG | 411 | Q96AP4 | |
| GRQWENLQGIRQGKP | 711 | Q63HK3 | |
| CQGGNLQQLLLWGVR | 281 | A6NGW2 | |
| IERQWGNLLGEGQHK | 241 | O15535 | |
| ILAIQQLGNGEWTQG | 816 | O15050 | |
| QLGNGEWTQGLQKRL | 821 | O15050 | |
| WQQGFRAKIPGLLNQ | 221 | P40225 | |
| NWATLAQKLGLGILN | 831 | P19838 |